OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway
Liwei Wu, Wenhui Mo, Jiao Feng, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 16, pp. 3760-3777
Open Access | Times Cited: 106

Showing 26-50 of 106 citing articles:

Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR
Qinmei Tan, Hanyu Chu, Jia Wang, et al.
Toxins (2024) Vol. 16, Iss. 9, pp. 401-401
Open Access | Times Cited: 7

Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
Alessio Carmignani, Matteo Battaglini, Martina Bartolucci, et al.
Materials & Design (2024) Vol. 239, pp. 112825-112825
Open Access | Times Cited: 6

Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response
Lu Wang, Xiaohui Wang, Lina Kong, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108159-108159
Closed Access | Times Cited: 38

LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Shizan Xu, Yajie Wang, Zhengyang Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 25

Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis
Yuhang Li, Juxiong Liu, Bojian Ye, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 34, pp. 10620-10634
Closed Access | Times Cited: 24

Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice
Qingcai Zhen, Qijian Liang, Hongchun Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15

Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1
Qi Mingming, Hui Zhong, Zhaoyan Cheng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 9184-9200
Closed Access | Times Cited: 15

Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
Shuo Li, Tiande Zou, Jun Chen, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101064-101064
Open Access | Times Cited: 15

Lycopene Alleviates Endoplasmic Reticulum Stress in Steatohepatitis through Inhibition of the ASK1–JNK Signaling Pathway
Xunyu Song, Jun Sun, Hanxiong Liu, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 14, pp. 7832-7844
Closed Access | Times Cited: 5

Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases
Wenji Zhang, Hui Lin, Wenli Cheng, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 16, pp. 4839-4859
Closed Access | Times Cited: 20

n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway
Yanfang Chen, Zekai Fan, Xiang Gao, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 123, pp. 109484-109484
Closed Access | Times Cited: 12

Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease
Zongqiang Hu, Hongyu Zhang, Yi‐Ting Wang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD
Jiahe Liu, Yuwei Zheng, Songya Yang, et al.
Phytomedicine (2024) Vol. 130, pp. 155756-155756
Closed Access | Times Cited: 4

Diet, oxidative stress and MAFLD: a mini review
Zhiai Hu, Hui Yue, Na Jiang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access

Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets
Yi Chu, Yang Su, Xiaodong Chen
Pharmacology & Therapeutics (2025), pp. 108844-108844
Closed Access

Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2
Honghai Xu, Zihao Wu, Jiangfeng Qin, et al.
Gut (2025), pp. gutjnl-334318
Closed Access

Gut–X Axis and Its Role in Poultry Bone Health: A Review
Lu Yanan, Tian-Xiang Yue, Wen-Li Ding, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 757-757
Open Access

Scroll to top